Alwin D. R. Huitema
Affiliations: | Netherlands Cancer Institute |
Area:
Clinical pharmacologyWebsite:
https://nl.linkedin.com/pub/alwin-huitema/62/818/540Google:
"Alwin Dagmar Redmar Huitema"Bio:
http://dap.library.uu.nl/cgi-bin/dap/dap?diss_id=13222
Mean distance: 12.61 | S | N | B | C | P |
Parents
Sign in to add mentor| Jos H. Beijnen | grad student | 2001 | Utrecht | |
| (Population pharmacokinetics and pharmacokinetically guided dosing of cyclophosphamide, thioTEPA and carboplatin in high-dose chemotherapy) | ||||
| Ron A.A. Mathôt | grad student | 2001 | Utrecht | |
| Sjoerd Rodenhuis | grad student | 2001 | Utrecht | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Akgöl K, van Merendonk LN, Barkman HJ, et al. (2023) Redispensing of expensive oral anticancer medicines: A practical application. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 10781552231176199 |
| van der Heijden L, van Nuland M, Beijnen J, et al. (2022) A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens. Clinical and Translational Science |
| Embaby A, van Merendonk L, Steeghs N, et al. (2022) Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose? Frontiers in Oncology. 12: 940582 |
| Joosten SEP, Wellenstein M, Koornstra R, et al. (2021) IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women. Npj Breast Cancer. 7: 138 |
| Geenen JJ, Dackus GM, Schouten PC, et al. (2021) A phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer. International Journal of Cancer |
| van Brummelen EMJ, Huijberts S, van Herpen C, et al. (2020) Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. The Oncologist. 26: 290-e545 |
| de Jong KA, van Breugel SJ, Hillebrand MJ, et al. (2020) Bottom-up sample preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies in bio matrices. Bioanalysis |
| Arnamo AH, Huitema AD, Beijnen JH, et al. (2019) Use of leftovers of monoclonal antibody products after partial extraction - A microbiological safety study. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155219850297 |
| van der Kaaij RT, Braam HJ, Boot H, et al. (2017) Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. Jmir Research Protocols. 6: e136 |
| Verheijen RB, Beijnen JH, Schellens JH, et al. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing. Clinical Pharmacokinetics |